Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2014
Recurrence patterns after resection of liver metastases from colorectal cancerHalfdan SorbyeEndocrinology and Metabolism Clinics of North America|August 13, 2018
The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and BeyondHalfdan Sorbye, Eric Baudin, Aurel PerrenEndocrine-Related Cancer|December 18, 2019
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)Halfdan Sorbye, Grace Kong, Simona Grozinsky-GlasbergJournal of Neuroendocrinology|September 7, 2024
PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC)Halfdan Sorbye, Grace Kong, Simona Grozinsky-Glasberg, et al.The Oncologist|April 5, 2022
Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine CarcinomasArvind Dasari, Chan Shen, Anjali Devabhaktuni, et al.Cancer|December 7, 2017
Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 casesArvind Dasari, Kathan Mehta, Lauren A Byers, et al.Cancer|April 2, 2011
Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapyStaffan Welin, Halfdan Sorbye, Sigrunn Sebjornsen, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 11, 2019
Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approachPaal Joranger, Arild Nesbakken, Halfdan Sorbye, et al.Cancer|April 29, 2014
Gastroenteropancreatic high-grade neuroendocrine carcinomaHalfdan Sorbye, Jonathan Strosberg, Eric Baudin, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 31, 2014
Modeling and validating the cost and clinical pathway of colorectal cancerPaal Joranger, Arild Nesbakken, Geir Hoff, et al.Pageof 10